Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor ‘knockout’ mice

Documenti analoghi

• The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene ‘knockout’ mice: Sex differences and implications for the treatment of attention deficit hyperactivity disorder
  di: Porter, Ashley J., et al.
  Pubblicazione: (2015)
• Perseveration by NK1R-/- (‘knockout’) mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test
  di: Pillidge, Katharine, et al.
  Pubblicazione: (2016)
• Differences in the performance of NK1R−/− (‘knockout’) and wildtype mice in the 5‑Choice Continuous Performance Test
  di: Porter, Ashley J., et al.
  Pubblicazione: (2016)
• The behavioural response of mice lacking NK(1) receptors to guanfacine resembles its clinical profile in treatment of ADHD
  di: Pillidge, Katharine, et al.
  Pubblicazione: (2014)
• The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder
  di: Pillidge, Katharine, et al.
  Pubblicazione: (2016)